compared with patients with other risk factors for endocarditis , patients with intravenous drug use were significantly more likely ( p less than .005 ) to suffer a recurrent bout of native-valve endocarditis within 12 months after the primary ( or previous ) episode .
C0014118
endocarditis
C1142550
native-valve endocarditis